Pharmaceutical composition for the prevention of the development and progression of mycotic skin surface diseases

摘要

This invention refers to pharmaceutical compositions applicable for the prevention of the development and progression of mycotic skin surface diseases in human and animal, in particular of those associated with the proliferation and conversion of commensal lipophile fungi, such as for instance the genus Malassezia/Pityrosporum. More in particular, this invention refers to a composition comprising a mixture of an agonist of the receptor of type CB2 of the cannabinoids and of a fatty acid sequestering resin.